The Atlantic's Katherine Wu discusses what we know -- and what we are still struggling to understand -- about long Covid.
Advisers to the Food and Drug Administration meet this week to assess the safety and effectiveness of two Covid-19 vaccines. This is a major step toward approval and distribution of the drugs. The first Americans, mostly health care workers, could start to receive the shots before the end of 2020. But public health officials warn it will take months before doses become widely available.
There will also be enormous hurdles to overcome along the way with distribution, but also convincing the public that this vaccine is safe.
Diane asked virologist Dr. Angela Rasmussen on the podcast to address some of those questions safety questions and clarify how the vaccine works. Dr. Rasmussen is an affiliate at the Georgetown Center for Global Health Science and Security.
- Angela Rasmussen Virologist and affiliate at the Georgetown Center for Global Health Science and Security
Most Recent Shows
As the war in Ukraine grinds on, a look at the economic battlefield and how the conflict might permanently reshape the global economy. Diane talks to Sebastian Mallaby, senior fellow for international economics at the Council on Foreign Relations.
David Gergen was a White House adviser to four presidents, then founded the Center for Public Leadership at Harvard. In a new book he explains what it takes to become a leader and why fresh leadership is so necessary in this country today.
Title IX turns 50 in June. Diane talks to Elizabeth Sharrow, expert on the history and consequences of the landmark sex discrimination law, about how it transformed women's sports -- and how much there is left to be done to achieve equality on the playing field.